Clinical trial
A Natural History Study of Biomarkers and Clinical Outcomes in Mucopolysaccharidosis Type IIIA (MPS IIIA)
NCT05523206 is registered in ClinicalTrials.gov with Sanguine Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Natural History Study of Biomarkers and Clinical Outcomes in Mucopolysaccharidosis Type IIIA (MPS IIIA)
- Lead sponsor
- Sanguine Biosciences
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 27, 2022
- Completion date
- January 28, 2025
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mucopolysaccharidosis iii-a